Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

Sheba Medical Center1 个研究点分布在 1 个国家目标入组 120 人开始时间: 2009年7月最近更新: 2009年6月3日

适应症

试验速览

阶段: 不适用
发起方: Sheba Medical Center
入组人数: 120
试验地点: 1

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba medical center, Israel. As well as correlate the degree of the presentation to the therapeutic protocol (chemotherapy and irradiation).

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Cross Sectional

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•after hematopoietic stem cell transplantation done at sheba medical center Israel
•3 month have past from transplantation but no more then 3 years

排除标准

•transplantation done in the last 3 month or more than 3 years have past since

研究者

发起方

Sheba Medical Center

申办方类型

Other Gov

研究点 (1)

Loading locations...

相似试验

尚未招募

不适用

Modification of ocular graft-versus-host disease development by early local Cyclosporin A application in patients after donor stem cell transplant.Ocular GVHDPreventive treatmentTopical Cyclosporine A

NL-OMON28561MC UtrechtHeidelberglaan 1003584 CX UtrechtThe Netherlands102

已完成

不适用

The Natural History of Graft-Versus-Host Disease in the EyesGraft-Versus-Host Disease

NCT01369914National Eye Institute (NEI)61

招募中

不适用

oGVHD After Bone Marrow Transplantation: a Territory-wide CohortGraft Vs Host DiseaseHaematological MalignancyCancer

NCT05170347The University of Hong Kong500

已完成

2 期

Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCTGraft-Versus-Host Disease

NCT02144025Hospital Universitario Dr. Jose E. Gonzalez21

已完成

不适用

Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) PatientsGVHDDry Eye

NCT02712762Singapore National Eye Centre5